Indications and Purposes
| Desvenlafaxine Extended-Release Tablet Is Indicated For The Treatment Of Adults With Major Depressive Disorder (Mdd) [See Clinical Studies (14)]. |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Desvenlafaxine Succinate |
|
ZINC2525885 |